Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 515-515 ◽  
Author(s):  
Wolfgang Janni ◽  
Brigitte Kathrin Rack ◽  
Peter A. Fasching ◽  
Lothar Haeberle ◽  
Hans Tesch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Adjuvant Chemotherapy ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Early Breast Cancer ◽  
Late Recurrence ◽  
Breast Cancer Patients

scholarly journals Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

2014 ◽  
Vol 106 (5) ◽  
Author(s):  
Brigitte Rack ◽  
Christian Schindlbeck ◽  
Julia Jückstock ◽  
Ulrich Andergassen ◽  
Philip Hepp ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Breast Cancer Patients ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer

scholarly journals Prognostic Value of Circulating Tumor Cells in Early Breast Cancer Patients Detected by RT-PCR of Mamaglobin

2012 ◽  
Vol 23 ◽  
pp. ix111-ix112
Author(s):  
A.M. Hilal ◽  
H.M. Elzawahrey ◽  
A.A. Abd Elwahab ◽  
M.N. Abdelhafez ◽  
M.M. Moneer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Early Breast Cancer ◽  
Prognostic Value ◽  
Breast Cancer Patients ◽  
Rt Pcr

Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients

2017 ◽  
Vol 33 ◽  
pp. 28-34 ◽  
Author(s):  
Georgios Z. Papadakis ◽  
Dimitrios Mavroudis ◽  
Vasilios Georgoulias ◽  
John Souglakos ◽  
Athanasios K. Alegakis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Igfbp 3

Prevalence of circulating tumor cells in early breast cancer patients 2 and 5 years after adjuvant treatment

2018 ◽  
Vol 171 (3) ◽  
pp. 571-580 ◽  
Author(s):  
Emanuel C. A. Bauer ◽  
◽  
Fabienne Schochter ◽  
Peter Widschwendter ◽  
Amelie DeGregorio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Early Breast Cancer ◽  
Adjuvant Treatment ◽  
Breast Cancer Patients

301 Survival in Early Breast Cancer Patients is Influenced by Circulating Tumor Cells

2012 ◽  
Vol 48 ◽  
pp. S130 ◽  
Author(s):  
B. Jäger ◽  
B. Rack ◽  
C. Schindlbeck ◽  
R. Lorenz ◽  
H. Tesch ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Early Breast Cancer ◽  
Breast Cancer Patients

scholarly journals Circulating Tumor Cells in Early Breast Cancer

2019 ◽  
Vol 3 (2) ◽  
Author(s):  
Laura Thery ◽  
Alessandra Meddis ◽  
Luc Cabel ◽  
Charlotte Proudhon ◽  
Aurelien Latouche ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Early Breast Cancer ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Level Of Evidence ◽  
Free Survival ◽  
Meta Analyses

AbstractCirculating tumor cells (CTCs) are particularly rare in non-metastatic breast cancer, and the clinical validity of CTC detection in that clinical setting was initially not well recognized. A cytological CTC detection device (CellSearch) fulfilling the CLIA requirements for analytical validity was subsequently developed and, in 2008, we reported the first study (REMAGUS02) showing that distant metastasis-free survival was shorter in early breast cancer patients with one or more CTCs. In the past 10 years, other clinical studies and meta-analyses have established CTC detection as a level-of-evidence 1 prognostic biomarker for local relapses, distant relapses, and overall survival. This review summarizes available data on CTC detection and the promises of this proliferation- and subtype-independent metastasis-associated biomarker in early breast cancer patients.

Sign in / Sign up

Export Citation Format

Share Document